The DOI matches its Crossref record; 326 of the 326 references it cites were found in a registry or an index.
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
Abstract
Guidelines for clinical practice are aimed to indicate preferred approaches to medical problems as established by scientifically valid research. Double-blind placebo controlled studies are preferable, but compassionate-use reports and expert review articles are used in a thorough review of the literature conducted through Medline with the National Library of Medicine. When only data that will not withstand objective scrutiny are available, a recommendation is identified as a consensus of experts. Guidelines are applicable to all physicians who address the subject regardless of specialty training or interests and are aimed to indicate the preferable but not necessarily the only acceptable approach to a specific problem. Guidelines are intended to be flexible and must be distinguished from standards of care, which are inflexible and rarely violated. Given the wide range of specifics in any health-care problem, the physician must always choose the course best suited to the individual patient and the variables in existence at the moment of decision. Guidelines are developed under the auspices of the American College of Gastroenterology and its Practice Parameters Committee and approved by the board of trustees. Each has been intensely reviewed and revised by the Committee, other experts in the field, physicians who will use them, and specialists in the science of decision analysis. The recommendations of each guideline are therefore considered valid at the time of composition based on the data available. New developments in medical research and practice pertinent to each guideline will be reviewed at a time established and indicated at publication to assure continued validity. The recommendations made are based on the level of evidence found. Grade A recommendations imply that there is consistent level 1 evidence (randomized controlled trials), grade B indicates that the evidence would be level 2 or 3, which are cohort studies or case-control studies. Grade C recommendations are based on level 4 studies, meaning case series or poor-quality cohort studies, and grade D recommendations are based on level 5 evidence, meaning expert opinion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoporosis Prevention, Diagnosis, and Therapy
NIH Consensus Development Panel on Osteoporosis Prevention, D. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.6.785 · Cited by 5,529
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,169
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Rutgeerts, P., Sandborn, W. J., Feagan, B. G., Reinisch, W., Olson, A., Johanns, J., Travers, S., Rachmilewitz, D., Hanauer, S. B., Lichtenstein, G. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050516 · Cited by 3,902
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis
Schroeder, K. W., Tremaine, W. J., & Ilstrup, D. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712243172603 · Cited by 3,026
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
Eaden, J. A., Abrams, K. R., & Mayberry, J. F. (2001) · Gut · doi:10.1136/gut.48.4.526 · Cited by 2,959
Cortisone in Ulcerative Colitis
Truelove, S. C., & Witts, L. J. (1955) · BMJ · doi:10.1136/bmj.2.4947.1041 · Cited by 2,767
Bongartz, T., Sutton, A. J., Sweeting, M. J., Buchan, I., Matteson, E. L., & Montori, V. (2006) · JAMA · doi:10.1001/jama.295.19.2275 · Cited by 2,468
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
Baert, F., Noman, M., Vermeire, S., Van Assche, G., D' Haens, G., Carbonez, A., & Rutgeerts, P. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020888 · Cited by 2,015
(2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.167.4.603 · Cited by 1,944
Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy
Lichtiger, S., Present, D. H., Kornbluth, A., Gelernt, I., Bauer, J., Galler, G., Michelassi, F., & Hanauer, S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406303302601 · Cited by 1,714
Self-citationChung, E. S., Packer, M., Lo, K. H., Fasanmade, A. A., & Willerson, J. T. (2003) · Circulation · doi:10.1161/01.cir.0000077913.60364.d2 · Cited by 1,644
Gionchetti, P., Rizzello, F., Venturi, A., Brigidi, P., Matteuzzi, D., Bazzocchi, G., Poggioli, G., Miglioli, M., & Campieri, M. (2000) · Gastroenterology · doi:10.1053/gast.2000.9370 · Cited by 1,486
Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U. A., Delmas, P. D., Malice, M.-P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390502 · Cited by 1,258
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis
Rutter, M., Saunders, B., Wilkinson, K., Rumbles, S., Schofield, G., Kamm, M., Williams, C., Price, A., Talbot, I., & Forbes, A. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.010 · Cited by 1,255
D’Haens, G., Sandborn, W. J., Feagan, B. G., Geboes, K., Hanauer, S. B., Irvine, E. J., Lémann, M., Marteau, P., Rutgeerts, P., Schölmerich, J., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.12.038 · Cited by 1,207
Weinshilboum, R. M., & Sladek, S. L. (1980) · PubMed · Cited by 1,195
Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial
Gionchetti, P., Rizzello, F., Helwig, U., Venturi, A., Lammers, K. M., Brigidi, P., Vitali, B., Poggioli, G., Miglioli, M., & Campieri, M. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00171-9 · Cited by 1,147
Mucosal Healing in Inflammatory Bowel Disease: Results From a Norwegian Population-Based Cohort
Frøslie, K. F., Jahnsen, J., Moum, B. A., & Vatn, M. H. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.051 · Cited by 1,121
Järnerot, G., Hertervig, E., Friis-Liby, I., Blomquist, L., Karlén, P., Grännö, C., Vilien, M., Ström, M., Danielsson, Å., Verbaan, H., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.003 · Cited by 1,089
Corticosteroid insufficiency in acutely ill patients
Cooper, M. S., & Stewart, P. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020529 · Cited by 1,033 · cited 1×
“Patients on chronic steroids are at risk of adrenal insufficiency if steroids are discontinued or tapered too rapidly, and therefore require steroid replacement at periods of increased stress, such as surgery (”
BackgroundRisk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease
Toruner, M., Loftus, E. V., Harmsen, W. S., Zinsmeister, A. R., Orenstein, R., Sandborn, W. J., Colombel, J., & Egan, L. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.012 · Cited by 1,017
Dubinsky, M. C., Lamothe, S., Yang, H. Y., Targan, S. R., Sinnett, D., Théorêt, Y., & Seidman, E. G. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70140-5 · Cited by 996
Lewis, J. D., Chuai, S., Nessel, L., Lichtenstein, G. R., Aberra, F. N., & Ellenberg, J. H. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20520 · Cited by 964
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease
Rutgeerts, P., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.014 · Cited by 943
Kappelman, M. D., Rifas–Shiman, S. L., Kleinman, K., Ollendorf, D., Bousvaros, A., Grand, R. J., & Finkelstein, J. A. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.07.012 · Cited by 932
Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis
Saag, K. G., Shane, E., Boonen, S., Marín, F., Donley, D. W., Taylor, K. A., Dalsky, G. P., & Marcus, R. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071408 · Cited by 914
Serious Infections and Mortality in Association With Therapies for Crohn’s Disease: TREAT Registry
Lichtenstein, G. R., Feagan, B. G., Cohen, R. D., Salzberg, B. A., Diamond, R. H., Chen, D. M., Pritchard, M. L., & Sandborn, W. J. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.002 · Cited by 905
Colombel, J.-F., Loftus, E. V., Tremaine, W. J., Egan, L. J., Harmsen, W. S., Schleck, C. D., Zinsmeister, A. R., & Sandborn, W. J. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.047 · Cited by 899
Kiesslich, R., Fritsch, J., Holtmann, M., Koehler, H. H., Stolte, M., Kanzler, S., Nafe, B., Jung, M., Galle, P. R., & Neurath, M. F. (2003) · Gastroenterology · doi:10.1053/gast.2003.50146 · Cited by 861
Eddy, D. M. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-3-214 · Cited by 837
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.
Broomé, U., Olsson, R., Lööf, L., Bodemar, G., Hultcrantz, R., Danielsson, A., Prytz, H., Sandberg-Gertzén, H., Wallerstedt, S., & Lindberg, G. (1996) · Gut · doi:10.1136/gut.38.4.610 · Cited by 819
Kandiel, A., Fraser, A. G., Korelitz, B. I., Brensinger, C., & Lewis, J. D. (2005) · Gut · doi:10.1136/gut.2004.049460 · Cited by 808
Pouchitis After Ileal Pouch-Anal Anastomosis: A Pouchitis Disease Activity Index
SANDBORN, W. J., TREMAINE, W. J., BATTS, K. P., PEMBERTON, J. H., & PHILLIPS, S. F. (1994) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)61634-6 · Cited by 778
Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced Osteoporosis
Adachi, J. D., Bensen, W. G., Brown, J., Hanley, D., Hodsman, A., Josse, R., Kendler, D. L., Lentle, B., Olszynski, W., Ste.-Marie, L.-G., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708073370603 · Cited by 685
Sutherland, L. R., Martin, F., Greer, S., Robinson, M., Greenberger, N., Saibil, F., Martin, T., Sparr, J., Prokipchuk, E., & Borgen, L. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90621-4 · Cited by 677
Thirty-Year Analysis of a Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis
Rutter, M. D., Saunders, B. P., Wilkinson, K. H., Rumbles, S., Schofield, G., Kamm, M. A., Williams, C. B., Price, A. B., Talbot, I. C., & Forbes, A. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.035 · Cited by 650
Brooklyn, T. N., Dunnill, M. G. S., Shetty, A., Bowden, J. J., Williams, J. D. L., Griffiths, C. E. M., Forbes, A., Greenwood, R., & Probert, C. S. (2006) · Gut · doi:10.1136/gut.2005.074815 · Cited by 646
Loftus, C. G., Loftus, E. V., Harmsen, S. W., Zinsmeister, A. R., Tremaine, W. J., Melton, J. L., & Sandborn, W. J. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20029 · Cited by 644
Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and Adults
Kappelman, M. D., Rifas–Shiman, S. L., Porter, C. Q., Ollendorf, D. A., Sandler, R. S., Galanko, J. A., & Finkelstein, J. A. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.09.012 · Cited by 634
The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review
Fraser, A. G. (2002) · Gut · doi:10.1136/gut.50.4.485 · Cited by 629
Colombel, J., Ferrari, N., Debuysere, H., Marteau, P., Gendre, J., Bonaz, B., Soulé, J.-C., Modigliani, R., Touze, Y., Catala, P., et al. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70354-4 · Cited by 619
Cohen, S., Levy, R. M., Keller, M., Boling, E., Emkey, R. D., Greenwald, M., Zizic, T. M., Wallach, S., Sewell, K. L., Lukert, B. P., et al. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199911)42:11<2309::aid-anr8>3.0.co;2-k · Cited by 613
Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?
Shanahan, F., Weinstein, W. M., & Bernstein, C. N. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90813-3 · Cited by 584
Colorectal cancer prevention in ulcerative colitis: a case‐control study
Eaden, Abrams, Ekbom, Jackson, & Mayberry (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00698.x · Cited by 577
Impact of Clostridium difficile on Inflammatory Bowel Disease
Issa, M., Vijayapal, A., Graham, M. B., Beaulieu, D. B., Otterson, M. F., Lundeen, S., Skaros, S., Weber, L. R., Komorowski, R. A., Knox, J. F., et al. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.12.028 · Cited by 570
Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis
Kane, S., Huo, D., Aikens, J., & Hanauer, S. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01383-9 · Cited by 569
Consensus Conference: Colorectal Cancer Screening and Surveillance in Inflammatory Bowel Disease
Itzkowitz, S. H., & Present, D. H. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000160811.76729.d5 · Cited by 564
Pardi, D. S., Loftus, E. V., Kremers, W. K., Keach, J., & Lindor, K. D. (2003) · Gastroenterology · doi:10.1053/gast.2003.50156 · Cited by 562
Penna, C., Dozois, R., Tremaine, W., Sandborn, W., LaRusso, N., Schleck, C., & Ilstrup, D. (1996) · Gut · doi:10.1136/gut.38.2.234 · Cited by 561
Blackstone, M. O., Riddell, R. H., Rogers, B. H. G., & Levin, B. (1981) · Gastroenterology · doi:10.1016/0016-5085(81)90727-7 · Cited by 556
INTENSIVE INTRAVENOUS REGIMEN FOR SEVERE ATTACKS OF ULCERATIVE COLITIS
Truelove, S. C., & Jewell, D. P. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90552-2 · Cited by 549
Velayos, F. S., Terdiman, J. P., & Walsh, J. M. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41442.x · Cited by 548
Kiesslich, R., Goetz, M., Lammersdorf, K., Schneider, C., Burg, J., Stolte, M., Vieth, M., Nafe, B., Galle, P. R., & Neurath, M. F. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.01.048 · Cited by 531
Incidence of Clostridium difficile Infection in Inflammatory Bowel Disease
Rodemann, J. F., Dubberke, E. R., Reske, K. A., Seo, D. H., & Stone, C. D. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.12.027 · Cited by 522
Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis
Rutter, M. D., Saunders, B. P., Schofield, G., Forbes, A., Price, A. B., & Talbot, I. C. (2004) · Gut · doi:10.1136/gut.2003.016386 · Cited by 520
Mackey, A. C., Green, L., Liang, L., Dinndorf, P., & Avigan, M. (2007) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31802f6424 · Cited by 506
Transdermal Nicotine for Active Ulcerative Colitis
Pullan, R. D., Rhodes, J., Ganesh, S., Mani, V., Morris, J. S., Williams, G. T., Newcombe, R. G., Russell, M., Feyerabend, C., Thomas, G., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403243301202 · Cited by 505
Ardizzone, S., Maconi, G., Russo, A., Imbesi, V, Colombo, E., & Bianchi Porro, G. (2006) · Gut · doi:10.1136/gut.2005.068809 · Cited by 505
Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres.
Gyde, S. N., Prior, P., Allan, R. N., Stevens, A., Jewell, D. P., Truelove, S. C., Lofberg, R., Brostrom, O., & Hellers, G. (1988) · Gut · doi:10.1136/gut.29.2.206 · Cited by 494
Ulcerative colitis in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival
Loftus, E. V., Silverstein, M. D., Sandborn, W. J., Tremaine, W. J., Harmsen, W. S., & Zinsmeister, A. R. (2000) · Gut · doi:10.1136/gut.46.3.336 · Cited by 492 · cited 1×
“UC affects approximately 500,000 individuals in the United States with an incidence of 8–12 per 100,000 population per year; the incidence has remained relatively constant over the last five decades (”
BackgroundThe incidence and management of infusion reactions to infliximab: a large center experience
Cheifetz, A. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00231-4 · Cited by 491
Dubinsky, M. C., Yang, H., Hassard, P. V., Seidman, E. G., Kam, L. Y., Abreu, M. T., Targan, S. R., & Vasiliauskas, E. A. (2002) · Gastroenterology · doi:10.1053/gast.2002.32420 · Cited by 483
Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential
Broomé, U., Löfberg, R., Veress, B., & Eriksson, L. S. (1995) · Hepatology · doi:10.1002/hep.1840220511 · Cited by 481
Targan, S. R., Landers, C. J., Yang, H., Lodes, M. J., Cong, Y., Papadakis, K. A., Vasiliauskas, E., Elson, C. O., & Hershberg, R. M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.046 · Cited by 476
A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis
Ogata, H., Matsui, T., Nakamura, M., Iida, M., Takazoe, M., Suzuki, Y., & Hibi, T. (2006) · Gut · doi:10.1136/gut.2005.081794 · Cited by 462
Thielman, N. M., & Guerrant, R. L. (2004) · New England Journal of Medicine · doi:10.1056/nejmcp031534 · Cited by 456
Case Reports of Heart Failure after Therapy with a Tumor Necrosis Factor Antagonist
Kwon, H. J., Cot, T. R., Cuffe, M. S., Kramer, J. M., & Braun, M. M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-10-200305200-00008 · Cited by 455
Randomised controlled trial of azathioprine withdrawal in ulcerative colitis.
Hawthorne, A. B., Logan, R. F., Hawkey, C. J., Foster, P. N., Axon, A. T., Swarbrick, E. T., Scott, B. B., & Lennard-Jones, J. E. (1992) · BMJ · doi:10.1136/bmj.305.6844.20 · Cited by 452
Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis
Connell, W. R., Lennard-Jones, J. E., Williams, C. B., Talbot, I. C., Price, A. B., & Wilkinson, K. H. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90216-x · Cited by 451
Family history as a risk factor for colorectal cancer in inflammatory bowel disease
Askling, J., Dickman, P. W., Ekbom, A., Karlén, P., Broström, O., Lapidus, A., & Löfberg, R. (2001) · Gastroenterology · doi:10.1053/gast.2001.24052 · Cited by 450
Fidder, H., Schnitzler, F., Ferrante, M., Noman, M., Katsanos, K., Segaert, S., Henckaerts, L., Van Assche, G., Vermeire, S., & Rutgeerts, P. (2009) · Gut · doi:10.1136/gut.2008.163642 · Cited by 449
Van Assche, G., D’haens, G., Noman, M., Vermeire, S., Hiele, M., Asnong, K., Arts, J., D’hoore, A., Penninckx, F., & Rutgeerts, P. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01214-9 · Cited by 448
Rutter, M. D., Saunders, B. P., Wilkinson, K. H., Rumbles, S., Schofield, G., Kamm, M. A., Williams, C. B., Price, A. B., Talbot, I. C., & Forbes, A. (2004) · Gut · doi:10.1136/gut.2003.038505 · Cited by 442
Walker, J. R., Ediger, J. P., Graff, L. A., Greenfeld, J. M., Clara, I., Lix, L., Rawsthorne, P., Miller, N., Rogala, L., McPhail, C. M., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01980.x · Cited by 437
Ananthakrishnan, A. N., McGinley, E. L., & Binion, D. G. (2008) · Gut · doi:10.1136/gut.2007.128231 · Cited by 426
Infliximab in the Treatment of Severe, Steroid-Refractory Ulcerative Colitis: A Pilot Study
Sands, B. E., Tremaine, W. J., Sandborn, W. J., Rutgeerts, P. J., Hanauer, S. B., Mayer, L., Targan, S. R., & Podolsky, D. K. (2001) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200105000-00001 · Cited by 422
Lichtenstein, G. R., Abreu, M. T., Cohen, R., & Tremaine, W. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.048 · Cited by 417
Nguyen, G. C., Kaplan, G. G., Harris, M. L., & Brant, S. R. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01780.x · Cited by 401
Hanauer, S. B. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603283341307 · Cited by 400
Velayos, F. S., Loftus, E. V., Jess, T., Harmsen, W. S., Bida, J., Zinsmeister, A. R., Tremaine, W. J., & Sandborn, W. J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.028 · Cited by 399
Osterman, M. T., Kundu, R., Lichtenstein, G. R., & Lewis, J. D. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.046 · Cited by 394
D'Haens, G., Lemmens, L., Nevens, F., Hiele, M., Rutgeerts, P., Vandeputte, L., Peeters, M., Vermeire, S., Geboes, K., Van Acker, F., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.23983 · Cited by 393
Colombel, J. F., Loftus, E. V., Tremaine, W. J., Pemberton, J. H., Wolff, B. G., Young-Fadok, T., Harmsen, W. S., Schleck, C. D., & Sandborn, W. J. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04148.x · Cited by 381
Olsen, K. Ø., Juul, S., Berndtsson, I., Öresland, T., & Laurberg, S. (2002) · Gastroenterology · doi:10.1053/gast.2002.30345 · Cited by 375
Waljee, A., Waljee, J., Morris, A. M., & Higgins, P. D. R. (2006) · Gut · doi:10.1136/gut.2005.090316 · Cited by 375
Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis
Ullman, T., Croog, V., Harpaz, N., Sachar, D., & Itzkowitz, S. (2003) · Gastroenterology · doi:10.1016/j.gastro.2003.08.023 · Cited by 374
Self-citationExtraintestinal manifestations in inflammatory bowel disease
Danese, S. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i46.7227 · Cited by 373
Nguyen, G. C., & Sam, J. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02052.x · Cited by 364
Intravenous cyclosporin in ulcerative colitis: a five-year experience
Cohen, R. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00205-1 · Cited by 363
Marteau, P., Probert, C. S., Lindgren, S., Gassul, M., Tan, T. G., Dignass, A., Befrits, R., Midhagen, G., Rademaker, J., & Foldager, M. (2005) · Gut · doi:10.1136/gut.2004.060103 · Cited by 362
CONTROLLED TRIAL OF SULPHASALAZINE IN MAINTENANCE THERAPY FOR ULCERATIVE COLITIS
Misiewicz, J. J., Lennard-Jones, J. E., Connell, A. M., Baron, J. H., & Avery Jones, F. (1965) · The Lancet · doi:10.1016/s0140-6736(65)90972-4 · Cited by 360
Jenkins, D., Balsitis, M., Gallivan, S., Dixon, M. F., Gilmour, H. M., Shepherd, N. A., Theodossi, A., & Williams, G. T. (1997) · Journal of Clinical Pathology · doi:10.1136/jcp.50.2.93 · Cited by 360
Rubin, P. H., Friedman, S., Harpaz, N., Goldstein, E., Weiser, J., Schiller, J., Waye, J. D., & Present, D. H. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70279-9 · Cited by 355
Aberra, F. N., Lewis, J. D., Hass, D., Rombeau, J. L., Osborne, B., & Lichtenstein, G. R. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00883-7 · Cited by 350
A Randomized Clinical Trial of Ciprofloxacin and Metronidazole to Treat Acute Pouchitis
Shen, B., Achkar, J.-P., Lashner, B. A., Ormsby, A. H., Remzi, F. H., Brzezinski, A., Bevins, C. L., Bambrick, M. L., Seidner, D. L., & Fazio, V. W. (2001) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200111000-00004 · Cited by 350
Cancer in universal and left-sided ulcerative colitis: Factors determining risk
Greenstein, A. J., Sachar, D. B., Smith, H., Pucillo, A., Papatestas, A. E., Kreel, I., Geller, S. A., Janowitz, H. D., & Aufses, A. H. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90279-8 · Cited by 343
Self-citationDissanayake, A. S., & Truelove, S. C. (1973) · Gut · doi:10.1136/gut.14.12.923 · Cited by 339
Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study
Pinczowski, D., Ekbom, A., Baron, J., Yuen, J., & Adami, H.-O. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90068-x · Cited by 337
Intensive intravenous treatment of ulcerative colitis
Järnerot, G., Rolny, P., & Sandberg-Gertzén, H. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90201-x · Cited by 333
Vermeire, S., Noman, M., Van Assche, G., Baert, F., Van Steen, K., Esters, N., Joossens, S., Bossuyt, X., & Rutgeerts, P. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00701-7 · Cited by 327 · cited 1×
“Fortunately, the development of a lupus-like illness occurs in fewer than 1p of patients (”
BackgroundHanauer, S. B., Sandborn, W. J., Kornbluth, A., Katz, S., Safdi, M., Woogen, S., Regalli, G., Yeh, C., Smith-Hall, N., & Ajayi, F. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00248.x · Cited by 322
Self-citationMost dysplasia in ulcerative colitis is visible at colonoscopy
Rutter, M. D., Saunders, B. P., Wilkinson, K. H., Kamm, M. A., Williams, C. B., & Forbes, A. (2004) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(04)01710-9 · Cited by 315
Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis.
Marshall, J. K., & Irvine, E. J. (1997) · Gut · doi:10.1136/gut.40.6.775 · Cited by 314
Surawicz, C. M., & Belic, L. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90595-x · Cited by 306
Cuffari, C., Hunt, S., & Bayless, T. M. (2001) · Gut · doi:10.1136/gut.48.5.642 · Cited by 306
Kaplan, G. G., McCarthy, E. P., Ayanian, J. Z., Korzenik, J., Hodin, R., & Sands, B. E. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.004 · Cited by 301
Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis
Cottone, M. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02413-8 · Cited by 301
Engelsgjerd, M., Farraye, F. A., & Odze, R. D. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70278-7 · Cited by 300
Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis
Madden, M. V., McIntyre, A. S., & Nicholls, R. J. (1994) · Digestive Diseases and Sciences · doi:10.1007/bf02093783 · Cited by 299
The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis
Lashner, B., Provencher, K., Seidner, D., Knesebeck, A., & Brzezinski, A. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70215-4 · Cited by 298
Moskovitz, D. N., Van Assche, G., Maenhout, B., Arts, J., Ferrante, M., Vermeire, S., & Rutgeerts, P. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.04.001 · Cited by 297
Oren, R., Arber, N., Odes, S., Moshkowitz, M., Keter, D., Pomeranz, I., Ron, Y., Reisfeld, I., Broide, E., Lavy, A., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8613046 · Cited by 297
AGA technical review on parenteral nutrition
Koretz, R. L., Lipman, T. O., & Klein, S. (2001) · Gastroenterology · doi:10.1053/gast.2001.28031 · Cited by 296
Dickinson, R. J., Ashton, M. G., Axon, A. T. R., Smith, R. C., Yeung, C. K., & Hill, G. L. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90913-0 · Cited by 293
Vasiliauskas, E., Plevy, S., Landers, C., Binder, S., Ferguson, D., Yang, H., Rotter, J., Vidrich, A., & Targan, Sr. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8964407 · Cited by 292
Ho, G. T., Mowat, C., Goddard, C. J. R., Fennell, J. M., Shah, N. B., Prescott, R. J., & Satsangi, J. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01945.x · Cited by 289
Out-patient Treatment of Ulcerative Colitis
Baron, J. H., Connell, A. M., Kanaghinis, T. G., Lennard-Jones, J. E., & Jones, F. A. (1962) · BMJ · doi:10.1136/bmj.2.5302.441 · Cited by 288
Hueting, W. E., Buskens, E., van der Tweel, I., Gooszen, H. G., & van Laarhoven, C. J. H. M. (2005) · Digestive Surgery · doi:10.1159/000085356 · Cited by 288
van Staa, T. P., Card, T., Logan, R. F., & Leufkens, H. G. M. (2005) · Gut · doi:10.1136/gut.2005.070896 · Cited by 287
SULPHASALAZINE AND SALICYLAZOSULPHADIMIDINE IN ULCERATIVE COLITIS
Baron, J. H., Connell, A. M., Lennard-Jones, J. E., & Avery Jones, F. (1962) · The Lancet · doi:10.1016/s0140-6736(62)92080-9 · Cited by 287
Marion, J. F., Waye, J. D., Present, D. H., Israel, Y., Bodian, C., Harpaz, N., Chapman, M., Itzkowitz, S., Steinlauf, A. F., Abreu, M. T., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01934.x · Cited by 287
Chapman, R. W., Selby, W. S., & Jewell, D. P. (1986) · Gut · doi:10.1136/gut.27.10.1210 · Cited by 284
Histopathology differentiates acute self-limited colitis from ulcerative colitis
Nostrant, T. T., Kumar, N. B., & Appelman, H. D. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90124-7 · Cited by 281
Cohen, R. D., Woseth, D. M., Thisted, R. A., & Hanauer, S. B. (2000) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.01940.x · Cited by 277
Hurst, R. D. (1996) · Archives of Surgery · doi:10.1001/archsurg.1996.01430170043007 · Cited by 271
Reese, G. E., Constantinides, V. A., Simillis, C., Darzi, A. W., Orchard, T. R., Fazio, V. W., & Tekkis, P. P. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00840.x · Cited by 267
Outcome of cytomegalovirus infections in patients with inflammatory bowel disease
Papadakis, K. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02512-6 · Cited by 267
Lichtenstein, G. R., Kamm, M. A., Boddu, P., Gubergrits, N., Lyne, A., Butler, T., Lees, K., Joseph, R. E., & Sandborn, W. J. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.10.025 · Cited by 267
Hanauer, S., SCHWARTZ, J., ROBINSON, M. G., Roufail, W. M., Arora, S., Cello, J. P., & Safdi, M. A. (1993) · PubMed · Cited by 266
Meta‐analysis: cancer risk of low‐grade dysplasia in chronic ulcerative colitis
THOMAS, T., ABRAMS, K. A., ROBINSON, R. J., & MAYBERRY, J. F. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03241.x · Cited by 266
Odze, R. D., Farraye, F. A., Hecht, J. L., & Hornick, J. L. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00237-x · Cited by 265
Hurlstone, D., Sanders, D., Lobo, A., McAlindon, M., & Cross, S. (2005) · Endoscopy · doi:10.1055/s-2005-921032 · Cited by 264
Sandborn, W. J., Tremaine, W. J., Offord, K. P., Lawson, G. M., Petersen, B. T., Batts, K. P., Croghan, I. T., Dale, L. C., Schroeder, D. R., & Hurt, R. D. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-5-199703010-00004 · Cited by 259
Controlled trial of bowel rest in the treatment of severe acute colitis.
McIntyre, P. B., Powell-Tuck, J., Wood, S. R., Lennard-Jones, J. E., Lerebours, E., Hecketsweiler, P., Galmiche, J. P., & Colin, R. (1986) · Gut · doi:10.1136/gut.27.5.481 · Cited by 255
Thiopurine-Induced Myelotoxicity in Patients With Inflammatory Bowel Disease: A Review
Gisbert, J. P., & Gomolln, F. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01848.x · Cited by 253
An index of disease activity in patients with ulcerative colitis
瀬尾, 充. (1991) · Medical Entomology and Zoology · doi:10.11501/3170085 · Cited by 253
ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease
Leighton, J. A., Shen, B., Baron, T. H., Adler, D. G., Davila, R., Egan, J. V., Faigel, D. O., Gan, S.-I., Hirota, W. K., Lichtenstein, D., et al. (2006) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2006.02.005 · Cited by 251
Shen, B., Achkar, J., Lashner, B. A., Bevins, C. L., Brzezinski, A., Ormsby, A. H., Petras, R. E., Remzi, F. H., & Fazio, V. W. (2001) · Gastroenterology · doi:10.1053/gast.2001.26290 · Cited by 251
Pathologic Features and Clinical Significance of ???Backwash??? Ileitis in Ulcerative Colitis
Haskell, H., Andrews, C. W., Reddy, S. I., Dendrinos, K., Farraye, F. A., Stucchi, A. F., Becker, J. M., & Odze, R. D. (2005) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000176435.19197.88 · Cited by 248
Cancer Surveillance in Ulcerative Colitis
Nugent, F. W., Haggitt, R. C., & Gilpin, P. A. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)70010-u · Cited by 247
Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
Rubin, D. T., Rothe, J. A., Hetzel, J. T., Cohen, R. D., & Hanauer, S. B. (2007) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2006.09.025 · Cited by 247
TREATMENT OF ULCERATIVE COLITIS WITH HIGH-DOSE 5-AMINOSALICYLIC ACID ENEMAS
Campieri, M., Lanfranchi, G. A., Bazzocchi, G., Franzin, G., Brignola, C., Battocchia, A., Sarti, F., Labo, G., & Dal Monte, P. R. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90523-7 · Cited by 245
The Risk for Cancer Or Dysplasia in Ulcerative Colitis Patients With Primary Sclerosing Cholangitis
Shetty, K., Rybicki, L. A., Brzezinski, A., Carey, W. D., & Lashner, B. A. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00212-9 · Cited by 245
Primary Sclerosing Cholangitis, Inflammatory Bowel Disease, and Colon Cancer
Broomé, U., & Bergquist, A. (2006) · Seminars in Liver Disease · doi:10.1055/s-2006-933561 · Cited by 244
TNFα blockade in human diseases: An overview of efficacy and safety
Lin, J., Ziring, D., Desai, S., Kim, S., Wong, M., Korin, Y., Braun, J., Reed, E., Gjertson, D., & Singh, R. R. (2008) · Clinical Immunology · doi:10.1016/j.clim.2007.08.012 · Cited by 244
Controlled trial of sulphasalazine in the treatment of ulcerative colitis
Dick, A. P., Grayson, M. J., Carpenter, R. G., & Petrie, A. (1964) · Gut · doi:10.1136/gut.5.5.437 · Cited by 243
Higher Incidence of Abnormal Pap Smears in Women With Inflammatory Bowel Disease
Kane, S., Khatibi, B., & Reddy, D. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01582.x · Cited by 240
Moody, G. A., Jayanthi, V, Probert, C. S. J., Kay, H. M., & Mayberry, J. F. (1996) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199612000-00009 · Cited by 240
Lix, L. M., Graff, L. A., Walker, J. R., Clara, I., Rawsthorne, P., Rogala, L., Miller, N., Ediger, J., Pretorius, T., & Bernstein, C. N. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20511 · Cited by 238
Gan, S. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00702-0 · Cited by 234
Controlled trial of azathioprine in chronic ulcerative colitis.
Kirk, A. P., & Lennard-Jones, J. E. (1982) · BMJ · doi:10.1136/bmj.284.6325.1291 · Cited by 228
High frequency of early colorectal cancer in inflammatory bowel disease
Lutgens, M. W. M. D., Vleggaar, F. P., Schipper, M. E. I., Stokkers, P. C. F., van der Woude, C. J., Hommes, D. W., de Jong, D. J., Dijkstra, G., van Bodegraven, A. A., Oldenburg, B., et al. (2008) · Gut · doi:10.1136/gut.2007.143453 · Cited by 228
Arts, J., D’Haens, G., Zeegers, M., Van Assche, G., Hiele, M., D’Hoore, A., Penninckx, F., Vermeire, S., & Rutgeerts, P. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200403000-00002 · Cited by 227
Lennard-Jones, J. E., Longmore, A. J., Newell, A. C., Wilson, C. W. E., & Jones, F. A. (1960) · Gut · doi:10.1136/gut.1.3.217 · Cited by 227
Benign and malignant colorectal strictures in ulcerative colitis.
Gumaste, V, Sachar, D. B., & Greenstein, A. J. (1992) · Gut · doi:10.1136/gut.33.7.938 · Cited by 226
Self-citationThe long-term outcome of ulcerative colitis treated with 6-mercaptopurine.
George, J. M., Present, D. H., Pou, R., Bodian, C., & Rubin, P. (1996) · PubMed · Cited by 225
A Controlled Trial of Azathioprine in the Management of Chronic Ulcerative Colitis
Rosenberg, J. L., Wall, A. J., Levin, B., Binder, H. J., & Kirsner, J. B. (1975) · Gastroenterology · doi:10.1016/s0016-5085(19)32641-1 · Cited by 224
Clark, M., Colombel, J.-F., Feagan, B. C., Fedorak, R. N., Hanauer, S. B., Kamm, M. A., Mayer, L., Regueiro, C., Rutgeerts, P., Sandborn, W. J., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.006 · Cited by 224
Observer study of the grading of dysplasia in ulcerative colitis: Comparison with clinical outcome
Melville, D. M., Jass, J. R., Morson, B. C., Pollock, D. J., Richman, P. I., Shepherd, N. A., Ritchie, J. K., Love, S. B., & Lennard-Jones, J. E. (1989) · Human Pathology · doi:10.1016/0046-8177(89)90273-6 · Cited by 222
Marchal, L., D'Haens, G., Van Assche, G., Vermeire, S., Noman, M., Ferrante, M., Hiele, M., Bueno De Mesquita, M., D'Hoore, A., Penninckx, F., et al. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01904.x · Cited by 222
5-Aminosalicylates and renal function in inflammatory bowel disease: A systematic review
Gisbert, J. P., González-Lama, Y., & Maté, J. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20099 · Cited by 220
Meta‐analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis
GISBERT, J. P., LINARES, P. M., MCNICHOLL, A. G., MATÉ, J., & GOMOLLÓN, F. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04023.x · Cited by 218
Guidelines for Immunizations in Patients With Inflammatory Bowel Disease
Sands, B. E., Cuffari, C., Katz, J., Kugathasan, S., Onken, J., Vitek, C., & Orenstein, W. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200409000-00028 · Cited by 217
Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis.
Azad Khan, A. K., Howes, D. T., Piris, J., & Truelove, S. C. (1980) · Gut · doi:10.1136/gut.21.3.232 · Cited by 215
The starved colon—Diminished mucosal nutrition, diminished absorption, and colitis
Roediger, W. E. W. (1990) · Diseases of the Colon & Rectum · doi:10.1007/bf02051922 · Cited by 214
Domènech, E., Vega, R., Ojanguren, I., Hernández, Á., Garcia-Planella, E., Bernal, I., Rosinach, M., Boix, J., Cabré, E., & Gassull, M. A. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20498 · Cited by 210
Ciclosporin use in acute ulcerative colitis: a long-term experience
Campbell, S., Travis, S., & Jewell, D. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200501000-00016 · Cited by 206
Shen, B. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)03973-4 · Cited by 206
Clayton, E. M., Rea, M. C., Shanahan, F., Quigley, E. M. M., Kiely, B., Hill, C., & Ross, R. P. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.4 · Cited by 202
Rectal aminosalicylate therapy for distal ulcerative colitis: a meta‐analysis
MARSHALL, J. K., & IRVINE, E. J. (1995) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1995.tb00384.x · Cited by 194
Colectomy rate in acute severe ulcerative colitis in the infliximab era
Aratari, A., Papi, C., Clemente, V., Moretti, A., Luchetti, R., Koch, M., Capurso, L., & Caprilli, R. (2008) · Digestive and Liver Disease · doi:10.1016/j.dld.2008.03.014 · Cited by 194
Riley, S. A., Mani, V, Goodman, M. J., Herd, M. E., Dutt, S., & Turnberg, L. A. (1988) · Gut · doi:10.1136/gut.29.5.669 · Cited by 193
Colorectal cancer in patients with ulcerative colitis
Gilat, T., Fireman, Z., Grossman, A., Hacohen, D., Kadish, U., Ron, E., Rozen, P., & Lilos, P. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90541-0 · Cited by 193
Transdermal Nicotine as Maintenance Therapy for Ulcerative Colitis
Thomas, G. A. O., Rhodes, J., Mani, V., Williams, G. T., Newcombe, R. G., Russell, M. A. H., & Feyerabend, C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321503 · Cited by 192
Green, J. R. B., Lobo, A. J., Holdsworth, C. D., Leicester, R. J., Gibson, J. A., Kerr, G. D., Hodgson, H. J. F., Parkins, K. J., & Taylor, M. D. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70627-4 · Cited by 191
Lofberg, R., Danielsson, A., Suhr, O., Nilsson, A., Schioler, R., Nyberg, A., Hultcrantz, R., Kollberg, B., Gillberg, R., Willen, R., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8964395 · Cited by 189
Medication Non-adherence is Associated with Increased Medical Health Care Costs
Kane, S., & Shaya, F. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9968-0 · Cited by 189
Azodisal sodium in the treatment of ulcerative colitis
Sandberg-Gertzén, H., Järnerot, G., & Kraaz, W. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90882-6 · Cited by 187
Dickinson, R. J., O'Connor, H. J., Pinder, I., Hamilton, I., Johnston, D., & Axon, A. T. (1985) · Gut · doi:10.1136/gut.26.12.1380 · Cited by 184
Fellermann, K. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00420-1 · Cited by 183
Baumgart, D. C., Pintoffl, J. P., Sturm, A., Wiedenmann, B., & Dignass, A. U. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00524.x · Cited by 182
Maser, E. A., Deconda, D., Lichtiger, S., Ullman, T., Present, D. H., & Kornbluth, A. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.04.035 · Cited by 181
Self-citationHIGGINS, P. D. R., RUBIN, D. T., KAULBACK, K., SCHOENFIELD, P. S., & KANE, S. V. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03865.x · Cited by 180
Hanauer, S. B., Robinson, M., Pruitt, R., Lazenby, A. J., Persson, T., Nilsson, L., Walton–Bowen, K., Haskell, L. P., & Levine, J. G. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70131-3 · Cited by 179
Comparison of Outcomes After Restorative Proctocolectomy With or Without Defunctioning Ileostomy
Weston-Petrides, G. K. (2008) · Archives of Surgery · doi:10.1001/archsurg.143.4.406 · Cited by 177
Kamm, M. A., Lichtenstein, G. R., Sandborn, W. J., Schreiber, S., Lees, K., Barrett, K., & Joseph, R. (2008) · Gut · doi:10.1136/gut.2007.138248 · Cited by 176
Riley, S. A., Mani, V., Goodman, M. J., Herd, M. E., Dutt, S., & Turnberg, L. A. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90677-4 · Cited by 173
SHEN, B., BRZEZINSKI, A., FAZIO, V. W., REMZI, F. H., ACHKAR, J. ‐., BENNETT, A. E., SHERMAN, K., & LASHNER, B. A. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02642.x · Cited by 173
Doherty, S. D., Van Voorhees, A., Lebwohl, M. G., Korman, N. J., Young, M. S., & Hsu, S. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.03.023 · Cited by 171
Shen, B., Lashner, B. A., Bennett, A. E., Remzi, F. H., Brzezinski, A., Achkar, J.-P., Bast, J., Bambrick, M. L., & Fazio, V. W. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30518.x · Cited by 170
KOHN, A., DAPERNO, M., ARMUZZI, A., CAPPELLO, M., BIANCONE, L., ORLANDO, A., VISCIDO, A., ANNESE, V., RIEGLER, G., MEUCCI, G., et al. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03415.x · Cited by 168
Acute surgical emergencies in inflammatory bowel disease
Berg, D. F., Bahadursingh, A. M., Kaminski, D. L., & Longo, W. E. (2002) · The American Journal of Surgery · doi:10.1016/s0002-9610(02)00879-6 · Cited by 168
5-aminosalicylic acids and the risk of renal disease: A large British epidemiologic study☆
Van Staa, T. P., Travis, S., Leufkens, H. G. M., & Logan, R. F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.016 · Cited by 168
Sandborn, W. J., Loftus, E. V., Colombel, J. F., Fleming, K. A., Seibold, F., Homburger, H. A., Sendid, B., Chapman, R. W., Tremaine, W. J., Kaul, D. K., et al. (2001) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200108000-00003 · Cited by 165
Hanauer, S. B., Sandborn, W. J., Dallaire, C., Archambault, A., Yacyshyn, B., Yeh, C., & Smith-Hall, N. (2007) · Canadian Journal of Gastroenterology · doi:10.1155/2007/862917 · Cited by 164
Budesonide enema in pouchitis—a double‐blind, double‐dummy, controlled trial
Sambuelli, A., Boerr, L., Negreira, S., Gil, A., Camartino, G., Huernos, S., Kogan, Z., Cabanne, A., Graziano, A., Peredo, H., et al. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01139.x · Cited by 164
Herrinton, L. J., Liu, L., Lewis, J. D., Griffin, P. M., & Allison, J. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01960.x · Cited by 160
Mantzaris, G. J., Petraki, K., Archavlis, E., Amberiadis, P., Kourtessas, D., Christidou, A., & Triantafyllou, G. (2001) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655201750305503 · Cited by 160
Hepatosplenic T cell lymphoma in inflammatory bowel disease: Table 1
Shale, M., Kanfer, E., Panaccione, R., & Ghosh, S. (2008) · Gut · doi:10.1136/gut.2008.163279 · Cited by 159
Cited by
Ungaro, R., Mehandru, S., Allen, P. B., Peyrin-Biroulet, L., & Colombel, J.-F. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32126-2 · Cited by 3,531
Silverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D., Bernstein, C. N., Brant, S. R., Caprilli, R., Colombel, J.-F., Gasche, C., Geboes, K., et al. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/269076 · Cited by 3,409
Self-citationLamb, C. A., Kennedy, N. A., Raine, T., Hendy, P. A., Smith, P. J., Limdi, J. K., Hayee, B., Lomer, M. C. E., Parkes, G. C., Selinger, C., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318484 · Cited by 2,346
Ordás, I., Eckmann, L., Talamini, M., Baumgart, D. C., & Sandborn, W. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60150-0 · Cited by 2,078
Inflammatory bowel disease: clinical aspects and established and evolving therapies
Baumgart, D. C., & Sandborn, W. J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60751-x · Cited by 1,920
Metadata
- Authors
- Kornbluth, A., & Sachar, D. B.
- Venue
- American Journal of Gastroenterology
- Published
- 2010-03
- Volume
- 105
- Issue
- 3
- Pages
- 501-523
- ISSN
- 0002-9270 (ISSN-L)
- OpenAlex
- W4295333203
- Cited by
- 2,023
- References
- 326
- FWCI
- 71.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.